Please login to the form below

Not currently logged in
Email:
Password:

New accounts: September

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period June to August 2005 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period June to August 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

Allergan

Botox

Neurology

Jango

Chiron Biopharma Europe

N/A

N/A

Woolley Pau

Galderma

New product

Dermatology

Life

Janssen-Cilag

Lyrinel XL

Urinary incontinence

PBC Communications

Link Pharmaceuticals

Gliadel implant

Oncology

Addjuice

Napp Pharmaceuticals

New product

Analgesia

Langland

Pfizer

New product

Ophthalmology

The Medical Multimedia Company

Roche Diagnostics

Cobas

Hospital in-vitro diagnostics

PBC Communications

Roche

New product

Oncology

MJL

Royal Free Hospital

Fundraising

HIV/HCV/HBV

MJL

Royal Numico (global)

Cubitan

Woundcare nutrition

central

Royal Numico (global)

Cubison

Woundcare nutrition

central

Strakan

Rectogesic

Anal fissures

VB Communications

2nd September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics